An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread

PHASE2CompletedINTERVENTIONAL
Enrollment

239

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

October 20, 2019

Study Completion Date

June 24, 2021

Conditions
Cancer
Interventions
BIOLOGICAL

Nivolumab

Specified dose on specified days

Trial Locations (45)

12200

Local Institution, Berlin

12206

USOR - New York Oncology Hematology, P.C., Albany

21044

Maryland Oncology Hematology P.A., Columbia

22031

Virginia Cancer Care Specialist, PC, Fairfax

24382

Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Wytheville

29615

Greenville Health System, Greenville

32806

Orlando Health, Inc, Orlando

33021

Memorial Healthcare System, Hollywood

33401

Florida Cancer Specialists, West Palm Beach

33705

Florida Cancer Specialists & Research Institute, St. Petersburg

34471

Florida Cancer Affiliates, Ocala

37090

Tennessee Oncology, Lebanon

38138

West Cancer Center, Germantown

45147

Local Institution, Essen

46845

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

53127

Local Institution, Bonn

55404

Minnesota Oncology Hematology, P.A., Minneapolis

60714

Illinois Cancer Specialists, Niles

64132

HCA Midwest Healthcare, Kansas City

68130

Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha

75246

Texas Oncology - Baylor Charles A. Simmons Cancer Center, Dallas

76104

Texas Oncology, P.A., Fort Worth

76712

Texas Oncology - Waco, Waco

77030

The University of Texas MD Anderson Cancer Center-merge, Houston

77380

Texas Oncology The Woodlands, The Woodlands

78240

Texas Oncology, P.A., San Antonio

79106

Local Institution, Freiburg im Breisgau

80218

Rocky Mountain Cancer Centers - Denver Midtwon, Denver

81501

St. Mary's Hospital And Regional Medical Center, Grand Junction

81675

Klinikum Rechts der Isar der Technischen Universitaet Muenchen, München

85711

Arizona Oncology Associates, PC, Tucson

89148

Texas Oncology-Austin Central, Las Vegas

90017

LACN, Los Angeles

90095

UCLA Main Campus - University California Los Angeles, Los Angeles

90277

Torrence Health Association, DBA Torrance Memorial;Physician Network/Cancer Care Associates, Redondo Beach

92835

St. Jude Hospital Yorba Linda, Fullerton

93105

Cancer Center of Santa Barbara with Sansum Clinic, Santa Barbara

93309

CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield

93401

Coastal Integrative Cancer Care, San Luis Obispo

93454

Central Coast Medical Oncology Corporation, Santa Maria

97062

Northwest Cancer Specialists, P.C., Tualatin

97477

Willamette Valley Cancer Institute and Research Center, Springfield

97504

Hematology Oncology Associates, PC, Medford

07039

Saint Barnabas Medical Cancer Center, Livingston

01307

Local Institution, Dresden

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY